Detail akcie Universe Pharma Rg online

Business Summary: Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
Financial Summary: BRIEF: For the fiscal year ended 30 September 2025, Universe Pharmaceuticals Inc revenues decreased 22% to $17.9M. Net loss decreased 58% to $3.7M. Revenues reflect Sales of third-party products segment decrease of 49% to $4.6M, Sales of TCMD products segment decrease of 5% to $13.3M. Lower net loss reflects China (Mainland) segment loss decrease of 64% to $2.9M.